Andrea Acosta - 30 Apr 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
GVP, Chief Accounting Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
30 Apr 2021
Net transactions value
-$5,557
Form type
4
Filing time
19 Jul 2021, 20:55:29 UTC
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $16,912 +271 +1.5% $62.41 18,407 30 Apr 2021 Direct F1
transaction BMRN Common Stock Tax liability $22,469 -285 -1.5% $78.84 18,122 16 Jul 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.